A Novel Pre-treatment Model Predicting Risk of Developing Refractoriness to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma

Background and aim: Refractoriness to transarterial chemoembolization is common during the therapeutic process of hepatocellular carcinoma, which is an intractable issue and may compromise the prognosis. We aim to establish a pre-treatment model to identify patients with high risks of refractoriness...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Keshu, Lu, Shenxin, Li, Miao, Zhang, Feng, Tang, Bei, Yuan, Jia, Shan, Yan, Xu, Pengju, Chen, Rongxin, Ren, Zhenggang, Yin, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255373/
https://www.ncbi.nlm.nih.gov/pubmed/32489476
http://dx.doi.org/10.7150/jca.44847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255373/
https://www.ncbi.nlm.nih.gov/pubmed/32489476
http://dx.doi.org/10.7150/jca.44847

Ejemplares similares